The global blood gas and electrolyte analyzer market accounted for USD 1.89 billion in 2023 and is expected to reach at USD 3.42 billion by 2034 with a CAGR of 5.54% during the forecast period 2024-2034. The uptick in intensive care units, emergency departments, & operation rooms admissions, a heightened need for streamlined systems, improved affordability for patients, increasing elderly population, increased healthcare spending on chronic conditions such as cancer & diabetes, growing advancements in technology, and surge in introduction of innovative blood gas and electrolyte analyzer devices are some of the key factors boosting the market growth.
Surge in introduction of innovative blood gas and electrolyte analyzer devices is predicted to boost the market growth during the forecast period. For instance, in July 2023, Siemens Healthineers AG, a prominent medical technology firm, unveiled the release of the latest Atellica CI Analyzer designed for clinical chemistry and immunoassay examinations. This analyzer allows independent laboratories as well as satellite facilities within extensive healthcare networks to utilize identical reagents, consumables, and advanced software available in the Atellica Solution by the company.
By product, portable was the highest revenue-grossing segment in the global blood gas and electrolyte analyzer market in 2023 owing to the capacity of portable analyzers to provide immediate test results and expedite turnaround times is increasing, and rising introduction of state-of-the-art analyzers. For instance, in February 2023, Chengdu Seamaty Technology Co., Ltd. introduced the SE1, a portable electrolyte analyzer capable of delivering laboratory-grade results within minutes. The SE1 is tailored to enhance patient care across a range of healthcare environments such as hospital bedside, urgent care clinics, and retail clinics. Additionally, benchtop is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend towards innovation & technological progress in creating new devices, transitioning from larger bench-top models to smaller, handheld, and stylish point-of-care devices.
By application, combined analyzers was the highest revenue-grossing segment in the global blood gas and electrolyte analyzer market in 2023 owing to a substantial test portfolio in addition to a broad range of marketed items. Additionally, blood gas analyzers is predicted to grow at the fastest CAGR during the forecast period owing to the increasing number of new devices being released and growing number of regulatory authority approvals. For instance, in June 2022, After receiving FDA approval, Sysmex America, Inc. added a capability to its XN-10 Automated Hematology Analyzer with Blood Bank Mode that counts leftover white blood cells (WBC).
By end-user, clinical laboratories was the highest revenue-grossing segment in the global blood gas and electrolyte analyzer market in 2023 owing to the increase in the utilization of diagnostic tests within these environments, and rising uptake of cutting-edge devices. Additionally, point-of-care is anticipated to grow at the fastest CAGR during the forecast period owing to the heightened efforts to decrease hospital stays in order to manage healthcare expenses, growing need for prompt diagnosis at the patient's site or close by, and increasing introduction of state-of-the-art devices. For instance, in July 2022, EDAN Instruments Inc., headquartered in China, unveiled the i20, a newly developed lightweight point-of-care (POC) system for fluorescence-based CO-oximetry blood gas and chemistry analysis. This system aims to alleviate the workload in targeted patient care environments such as intensive care units (ICUs), neonatal ICUs, pulmonary units, and operating rooms.
North America region is anticipated for the highest revenue share during the forecast period owing to the existence of a large number of skilled practitioners, robust healthcare infrastructure, continuous technological advancements, escalating governmental backing for research & development endeavors, and surge in technological progress. For instance, in December 2023, Inspira Technologies OXY BHN Ltd., a company specializing in life support technology aiming to surpass conventional mechanical ventilators, has introduced an enhancement in its sensor technology known as the HYLA Blood Sensor. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of unmet clinical needs, escalating healthcare costs, heightened patient awareness, and surge in the introduction of new devices by market participants. For instance, in June 2023, B&E Biotechnology Co. Ltd. unveiled the i-Check, a handheld blood gas and electrolyte analyzer.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Surge in introduction of innovative blood gas and electrolyte analyzer devices is predicted to boost the market growth during the forecast period. For instance, in July 2023, Siemens Healthineers AG, a prominent medical technology firm, unveiled the release of the latest Atellica CI Analyzer designed for clinical chemistry and immunoassay examinations. This analyzer allows independent laboratories as well as satellite facilities within extensive healthcare networks to utilize identical reagents, consumables, and advanced software available in the Atellica Solution by the company.
By product, portable was the highest revenue-grossing segment in the global blood gas and electrolyte analyzer market in 2023 owing to the capacity of portable analyzers to provide immediate test results and expedite turnaround times is increasing, and rising introduction of state-of-the-art analyzers. For instance, in February 2023, Chengdu Seamaty Technology Co., Ltd. introduced the SE1, a portable electrolyte analyzer capable of delivering laboratory-grade results within minutes. The SE1 is tailored to enhance patient care across a range of healthcare environments such as hospital bedside, urgent care clinics, and retail clinics. Additionally, benchtop is predicted to grow at the fastest CAGR during the forecast period owing to the growing trend towards innovation & technological progress in creating new devices, transitioning from larger bench-top models to smaller, handheld, and stylish point-of-care devices.
By application, combined analyzers was the highest revenue-grossing segment in the global blood gas and electrolyte analyzer market in 2023 owing to a substantial test portfolio in addition to a broad range of marketed items. Additionally, blood gas analyzers is predicted to grow at the fastest CAGR during the forecast period owing to the increasing number of new devices being released and growing number of regulatory authority approvals. For instance, in June 2022, After receiving FDA approval, Sysmex America, Inc. added a capability to its XN-10 Automated Hematology Analyzer with Blood Bank Mode that counts leftover white blood cells (WBC).
By end-user, clinical laboratories was the highest revenue-grossing segment in the global blood gas and electrolyte analyzer market in 2023 owing to the increase in the utilization of diagnostic tests within these environments, and rising uptake of cutting-edge devices. Additionally, point-of-care is anticipated to grow at the fastest CAGR during the forecast period owing to the heightened efforts to decrease hospital stays in order to manage healthcare expenses, growing need for prompt diagnosis at the patient's site or close by, and increasing introduction of state-of-the-art devices. For instance, in July 2022, EDAN Instruments Inc., headquartered in China, unveiled the i20, a newly developed lightweight point-of-care (POC) system for fluorescence-based CO-oximetry blood gas and chemistry analysis. This system aims to alleviate the workload in targeted patient care environments such as intensive care units (ICUs), neonatal ICUs, pulmonary units, and operating rooms.
North America region is anticipated for the highest revenue share during the forecast period owing to the existence of a large number of skilled practitioners, robust healthcare infrastructure, continuous technological advancements, escalating governmental backing for research & development endeavors, and surge in technological progress. For instance, in December 2023, Inspira Technologies OXY BHN Ltd., a company specializing in life support technology aiming to surpass conventional mechanical ventilators, has introduced an enhancement in its sensor technology known as the HYLA Blood Sensor. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing prevalence of unmet clinical needs, escalating healthcare costs, heightened patient awareness, and surge in the introduction of new devices by market participants. For instance, in June 2023, B&E Biotechnology Co. Ltd. unveiled the i-Check, a handheld blood gas and electrolyte analyzer.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product, Application, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Blood Gas And Electrolyte Analyzer Market Report 2023 - 2034
Blood Gas And Electrolyte Analyzer Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Portable
- Benchtop
Blood Gas And Electrolyte Analyzer Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Combined Analyzers
- Electrolyte Analyzers
- Blood Gas Analyzers
Blood Gas And Electrolyte Analyzer Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Point-of-Care
- Clinical Laboratories
Blood Gas And Electrolyte Analyzer Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Blood Gas And Electrolyte Analyzer Market: Product Estimates & Trend Analysis
8. Blood Gas And Electrolyte Analyzer Market: Application Estimates & Trend Analysis
9. Blood Gas And Electrolyte Analyzer Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Blood Gas And Electrolyte Analyzer Market
12. Europe Global Blood Gas And Electrolyte Analyzer Market
13. Asia Pacific Global Blood Gas And Electrolyte Analyzer Market
14. Latin America Global Blood Gas And Electrolyte Analyzer Market
15. MEA Global Blood Gas And Electrolyte Analyzer Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- ERBA Diagnostics Mannheim GmbH
- EDAN Instruments Inc.
- Radiometer Medical ApS
- F Hoffman La Roche Ltd.
- Medica Corporation
- Sensa Core
- Instrumentation Laboratories
- Siemens Medical Solutions USA Inc.
- Cornley Hi-tech Co. Ltd
- LifeHealth
- Nova Biomedical Corporation
- Abbott Point of Care Inc.
- OPTI Medical Systems Inc.
- Fortress Diagnostics
